CeeNU, also known by its generic name lomustine, is a chemotherapy medication used for the treatment of certain types of cancer. It belongs to the class of alkylating agents, which work by interfering with the DNA replication process in cancer cells, thereby inhibiting their growth and division.
CeeNU is primarily prescribed for the treatment of brain tumors, including glioblastoma multiforme, anaplastic astrocytoma, and metastatic brain tumors. It is also used in combination with other chemotherapy drugs for the treatment of Hodgkin's disease, multiple myeloma, and advanced melanoma.
The medication is typically administered orally in the form of capsules, but it may also be given directly into the bloodstream through intravenous injection. The dosage and treatment duration vary depending on the specific type and stage of cancer being treated, as well as the patient's overall health condition and response to therapy.
While CeeNU can be an effective treatment option for certain types of cancer, it carries the risk of various side effects. Common side effects include nausea, vomiting, loss of appetite, bone marrow suppression, which may increase the risk of infection or bleeding, and liver toxicity. Regular blood tests are usually performed during treatment to monitor the patient's blood cells, liver function, and overall response to therapy.
It is important for individuals taking CeeNU to closely follow their healthcare provider's instructions and report any concerning side effects or changes in their condition.
